|
T.A. Meleshkevich (1, 2), E.I. Luchina (1), M.E. Lukashova (1)
THE USE OF ACTOVEGIN AS A UNIVERSAL METHOD FOR THE TREATMENT OF DIABETES COMPLICATIONS
|
№18 / 2014
|
|
V.N. Khramilin, V.L. Andreeva, I.Yu. Demidova
COMBINATION THERAPY OF PAINFUL DIABETIC POLYNEUROPATHY: RESULTS OF PILOT STUDY
|
№16 / 2014
|
|
O.V. Zanozina, Yu.A. Sorokina, L.V. Lovtsova, N.N. Borovkov
ANALYSIS OF THE EFFICACY AND SAFETY OF DOMESTIC INSULIN NPH RINSULIN IN NIZHNY NOVGOROD
|
№16 / 2014
|
|
S.V. Shalaev (1, 2), Z.M. Safiullina (1), N.A. Mikhalchuk (1)
STATINS AND THE RISK FOR NEW-ONSET DIABETES: RISK-BENEFIT RATIO. MODERN VIWES ON TARGET LIPID LEVELS IN DIABETES PATIENTS
|
№16 / 2014
|
|
E.V. Doskina
DIABETES MELLITUS AND OSTEOPOROSIS. ANALYSIS OF COMBINED APPROACH TO THE TREATMENT
|
№s5-14 / 2014
|
|
I.V. Maev, A.N. Kazyulin, S.M. Babina
THE USE OF USING DRUGS MADE BY NEW TECHNOLOGIES IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
|
№14 / 2014
|
|
D.V. Akimova
RISK FACTORS FOR OSTEOPOROSIS
|
№7 / 2014
|
|
N.Yu. Arbatskaya (1,2)
FEATURES OF GLUCOSE-LOWERING TREATMENT DURING PREGNANCY
|
№5 / 2014
|
|
I.V. Kononenko, O.M. Smirnova
DIABETES MELLITUS: FROM UNDERSTANDING OF CAUSES TO THE CHOICE OF TREATMENT
|
№5 / 2014
|
|
L.A. Sharonova (1), A.F. Verbovoy (1), D.Yu. Sharonova (2)
CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT OF DIABETIC NEUROPATHY
|
№5 / 2014
|
|
O.L.Badalyan , A.A.Savenkov
PATHOGENETIC APPROACHES TO THE THERAPY OF DIABETIC POLYNEUROPATHY
|
№5 / 2014
|
|
M.E.Statsenko (1), A.A.Vinnikova (1), N.N.Shilina (1), A.M.Ronskaya (2)
POTENTIALS OF DIBICOR IN IN CORRECTION OF METABOLIC AND VASCULAR ABNORMALITIES IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
Русский
